Meiyun Tan

564 citations
23 papers · 405 indexed · h-index 11
Topics
Tissue Engineering and Regenerative Medicine (8 papers)Mesenchymal stem cell research (7 papers)Cancer, Hypoxia, and Metabolism (3 papers)

In The Last Decade

Meiyun Tan

21 papers receiving 396 citations

Peers

Meiyun Tan
Comparison fields: 5 of 70
  • Surgery 205
  • Molecular Biology 118
  • Biomaterials 108
  • Genetics 107
  • Cancer Research 73
Replace Song-Yi Lee with:
Song-Yi Lee South Korea
Elisa Gambini Italy
Gangyong Huang China
Naimisha Beeravolu United States
Ashkaun Shaterian United States
Maciej Kabat United States
Zurab Kakabadze Georgia
Sachin S. Vaikunth United States
F. Mensah Netherlands
Chee‐Yin Wong Malaysia
Meiyun Tan relative to Song-Yi Lee South Korea Song-Yi Lee's profile →
Citations per field
00.5×1.5×2.3×
Song-Yi Lee · 1×
Citations per year

Countries citing papers authored by Meiyun Tan

Since Specialization
Citations

This map shows the geographic impact of Meiyun Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiyun Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiyun Tan more than expected).

Fields of papers citing papers by Meiyun Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiyun Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiyun Tan. The network helps show where Meiyun Tan may publish in the future.

Co-authorship network of co-authors of Meiyun Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Meiyun Tan. A scholar is included among the top collaborators of Meiyun Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiyun Tan. Meiyun Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 14
4 9
5 11
6
Gut microbiota can affect bone quality by regulating serum estrogen levels.
6
7 9
8 6
9 6
10 3
11 59
12 6
13
[HEMOSTASIS EFFECT OF COMPRESSION DRESSING THERAPY AFTER TOTAL HIP ARTHROPLASTY].
3
14 14
15 15
16 51
17 68
18 53
19 12
20 15

About Meiyun Tan

Meiyun Tan is a scholar working on Genetics, Cancer Research and Anesthesiology and Pain Medicine, having authored 23 papers that have together received 405 indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (8 papers), Mesenchymal stem cell research (7 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Genetics (107 citations), Biomaterials (108 citations) and Cancer Research (73 citations). Meiyun Tan has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xiuqun Li, Xiaohe Chen, Huiqi Xie, Yong‐Can Huang, Xiaobo Lu, Li Deng, Ge Chen, Li Deng, Zhong Li and Bo Tan. Their work appears in journals such as PLoS ONE, Scientific Reports and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026